Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
TEVA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
36.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
27.90%
TEVA Stock Analysis
TEVA
PE Ratio:
24.7
TEVA
PEG Ratio:
0.8
TEVA
Forward EPS Growth (12 month):
32.20%
TEVA
PS Ratio:
2.2
TEVA
PSG Ratio:
0.5
TEVA
Forward Revenue Growth (12 month):
4.10%
TEVA Articles
No data was found